What question did this study set out to answer?

Review the histological spectrum, grading and staging systems, and clinical necessity of liver biopsy across nonalcoholic fatty liver disease presentations.

July 21, 2014Open Access

Role of liver biopsy in nonalcoholic fatty liver disease.

View Full Paper

Ask AI

Bookmark

Why the study?

Does liver biopsy remain the gold standard for diagnosing and staging NAFLD compared to non-invasive testing?

Population

Adults and children with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)

Comparison

Liver biopsy vs Non-invasive testing

Design

Review

Authors

INILKe NalbantogluYale New Haven Hospital EBElizabeth M. BruntUniversity of Southern California

Discussion

Member takes

Implication

Supports biopsy for detailed NASH histology in trials and select cases; leaves open validation of non-invasive tests.

Key Points

Review the histological spectrum, grading and staging systems, and clinical necessity of liver biopsy across nonalcoholic fatty liver disease presentations.
Reviewed diagnostic criteria and staging frameworks for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Evaluated the NASH Clinical Research Network system, European diagnostic proposals, and non-invasive testing modalities against tissue examination.
Liver biopsy remains the reference standard for diagnosing NASH, distinguishing simple steatosis from steatohepatitis, and grading necroinflammatory activity.
Histopathologic assessment uniquely maps architectural remodeling and fibrosis distribution, providing critical clinical details that non-invasive surrogates cannot currently replicate.

Structured PICO

Does liver biopsy remain the gold standard for diagnosing and staging NAFLD compared to non-invasive testing?

Population

Adults and children with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)

Intervention

Liver biopsy

Comparator

Non-invasive testing

Outcome

Diagnosis, grading, and staging of NAFLD and NASH

Despite advances in non-invasive testing, liver biopsy remains the gold standard for the detailed histologic evaluation of NAFLD and NASH.

Limitations

Limitations of biopsy are acknowledged

Cite This Study

Nalbantoglu et al. (2014) studied this question.

synapsesocial.com/papers/6a71180bac440176ef29c679 https://doi.org/10.3748/wjg.v20.i27.9026

View Full Paper

Ask AI

Bookmark

Role of liver biopsy in nonalcoholic fatty liver disease.

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Role of liver biopsy in nonalcoholic fatty liver disease.

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider